These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

601 related items for PubMed ID: 18578001

  • 1. The role of regulatory T cells in multiple sclerosis.
    Zozulya AL, Wiendl H.
    Nat Clin Pract Neurol; 2008 Jul; 4(7):384-98. PubMed ID: 18578001
    [Abstract] [Full Text] [Related]

  • 2. The role of CD8 suppressors versus destructors in autoimmune central nervous system inflammation.
    Zozulya AL, Wiendl H.
    Hum Immunol; 2008 Nov; 69(11):797-804. PubMed ID: 18723060
    [Abstract] [Full Text] [Related]

  • 3. Polyclonal expansion of regulatory T cells interferes with effector cell migration in a model of multiple sclerosis.
    Tischner D, Weishaupt A, van den Brandt J, Müller N, Beyersdorf N, Ip CW, Toyka KV, Hünig T, Gold R, Kerkau T, Reichardt HM.
    Brain; 2006 Oct; 129(Pt 10):2635-47. PubMed ID: 16921176
    [Abstract] [Full Text] [Related]

  • 4. Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis.
    Huang YH, Zozulya AL, Weidenfeller C, Metz I, Buck D, Toyka KV, Brück W, Wiendl H.
    Ann Neurol; 2009 Aug; 66(2):171-83. PubMed ID: 19705413
    [Abstract] [Full Text] [Related]

  • 5. Regulation of experimental autoimmune encephalomyelitis (EAE) by CD4+CD25+ regulatory T cells.
    Kohm AP, Carpentier PA, Miller SD.
    Novartis Found Symp; 2003 Aug; 252():45-52; discussion 52-4, 106-14. PubMed ID: 14609211
    [Abstract] [Full Text] [Related]

  • 6. Emerging concepts in autoimmune encephalomyelitis beyond the CD4/T(H)1 paradigm.
    Batoulis H, Addicks K, Kuerten S.
    Ann Anat; 2010 Aug 20; 192(4):179-93. PubMed ID: 20692821
    [Abstract] [Full Text] [Related]

  • 7. [Role of T-regulatory cells in multiple sclerosis].
    Rojas JI, González SJ, Patrucco L, Cristiano E.
    Medicina (B Aires); 2010 Aug 20; 70(1):79-86. PubMed ID: 20228030
    [Abstract] [Full Text] [Related]

  • 8. T-cells in multiple sclerosis.
    Severson C, Hafler DA.
    Results Probl Cell Differ; 2010 Aug 20; 51():75-98. PubMed ID: 19582415
    [Abstract] [Full Text] [Related]

  • 9. Role of regulatory T-cells in autoimmunity.
    Mellanby RJ, Thomas DC, Lamb J.
    Clin Sci (Lond); 2009 Apr 20; 116(8):639-49. PubMed ID: 19275768
    [Abstract] [Full Text] [Related]

  • 10. Immunological basis for the development of tissue inflammation and organ-specific autoimmunity in animal models of multiple sclerosis.
    Korn T, Mitsdoerffer M, Kuchroo VK.
    Results Probl Cell Differ; 2010 Apr 20; 51():43-74. PubMed ID: 19513635
    [Abstract] [Full Text] [Related]

  • 11. T-cell vaccination in multiple sclerosis: update on clinical application and mode of action.
    Hellings N, Raus J, Stinissen P.
    Autoimmun Rev; 2004 Jun 20; 3(4):267-75. PubMed ID: 15246022
    [Abstract] [Full Text] [Related]

  • 12. Autoreactive T lymphocytes in multiple sclerosis: pathogenic role and therapeutic targeting.
    Stinissen P, Raus J.
    Acta Neurol Belg; 1999 Mar 20; 99(1):65-9. PubMed ID: 10218096
    [Abstract] [Full Text] [Related]

  • 13. CD4(+)CD25 (+) regulatory T cells in human lupus erythematosus.
    Kuhn A, Beissert S, Krammer PH.
    Arch Dermatol Res; 2009 Jan 20; 301(1):71-81. PubMed ID: 18985367
    [Abstract] [Full Text] [Related]

  • 14. Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis.
    Beyersdorf N, Gaupp S, Balbach K, Schmidt J, Toyka KV, Lin CH, Hanke T, Hünig T, Kerkau T, Gold R.
    J Exp Med; 2005 Aug 01; 202(3):445-55. PubMed ID: 16061730
    [Abstract] [Full Text] [Related]

  • 15. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice.
    Kim JM, Rasmussen JP, Rudensky AY.
    Nat Immunol; 2007 Feb 01; 8(2):191-7. PubMed ID: 17136045
    [Abstract] [Full Text] [Related]

  • 16. [Activation of T cells in experimental autoimmune encephalomyelitis and multiple sclerosis].
    Rodríguez-Rodríguez Y, Suárez-Luis I.
    Rev Neurol; 2007 Feb 01; 36(7):649-52. PubMed ID: 12666047
    [Abstract] [Full Text] [Related]

  • 17. Mitoxantrone does not restore the impaired suppressive function of natural regulatory T cells in patients suffering from multiple sclerosis. A longitudinal ex vivo and in vitro study.
    Putzki N, Kumar M, Kreuzfelder E, Grosse-Wilde H, Diener HC, Limmroth V.
    Eur Neurol; 2009 Feb 01; 61(1):27-32. PubMed ID: 18948697
    [Abstract] [Full Text] [Related]

  • 18. Early life exposure to lipopolysaccharide suppresses experimental autoimmune encephalomyelitis by promoting tolerogenic dendritic cells and regulatory T cells.
    Ellestad KK, Tsutsui S, Noorbakhsh F, Warren KG, Yong VW, Pittman QJ, Power C.
    J Immunol; 2009 Jul 01; 183(1):298-309. PubMed ID: 19542441
    [Abstract] [Full Text] [Related]

  • 19. The CD8 T cell in multiple sclerosis: suppressor cell or mediator of neuropathology?
    Johnson AJ, Suidan GL, McDole J, Pirko I.
    Int Rev Neurobiol; 2007 Jul 01; 79():73-97. PubMed ID: 17531838
    [Abstract] [Full Text] [Related]

  • 20. Neuroinflammation in multiple sclerosis: evidence for autoimmune dysregulation, not simple autoimmune reaction.
    Grigoriadis N, Grigoriadis S, Polyzoidou E, Milonas I, Karussis D.
    Clin Neurol Neurosurg; 2006 Mar 01; 108(3):241-4. PubMed ID: 16388896
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.